Agonist anti-CD137 (4-1BB) mAbs enhance CD8-mediated antitumor immunity. Agonist anti-human
CD137 mAbs binding to four distinct epitopes on the CD137 glycoprotein …

The hypoxic response in cells and tissues is mediated by the family of hypoxia-inducible
factor (HIF) transcription factors; these play an integral role in the metabolic changes that drive …

Both malignant and stromal components in tumors are influenced by the physiologic conditions
of the microenvironment. Hypoxia is a prominent feature of solid tumors as a result of …

COVID-19 is a systemic infection that exerts significant impact on the metabolism. Yet, there
is little information on how SARS-CoV-2 affects metabolism. Using NMR spectroscopy, we …

The tumor microenvironment of transplanted and spontaneous mouse tumors is profoundly
deprived of oxygenation as confirmed by positron emission tomographic (PET) imaging. CD8 …

Agonist monoclonal antibodies (mAb) to the immune costimulatory molecule CD137, also
known as 4-1BB, are presently in clinical trials for cancer treatment on the basis of their …

The glycan structures of the receptor binding domain of the SARS‐CoV2 spike glycoprotein
expressed in human HEK293F cells have been studied by using NMR. The different …

Chimeric antigen receptor (CAR) T cell therapies have demonstrated remarkable efficacy
for the treatment of hematological malignancies. However, in patients with solid tumors, …

The tumor microenvironment (TME) is reprogrammed by cancer cells and participates in all
stages of tumor progression. The contribution of stromal cells to the reprogramming of the …

Migration of DC into lymphatic vessels ferries antigenic cargo and pro‐inflammatory stimuli
into the draining LN. Given that tissues under the influence of viral infections produce type I …